Stockreport

Cognition Therapeutics CEO Participating in Longwood and Sachs Conferences

Cognition Therapeutics, Inc.  (CGTX) 
PDF PURCHASE, N.Y., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drug [Read more]